Apecotrep

N/A

Report date: 2026/05/23 20:00:57
NME

Base Information

Drug NameApecotrep
Drug Alias NameBI-764198
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionShort transient receptor potential channel 6 inhibitors
TargetsShort transient receptor potential channel 6
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)ProteinuriaRenal Insufficiency, Chronic +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[39] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesC.H. Boehringer Sohn Ag & Co. KgBoehringer Ingelheim International GmbhBoehringer Ingelheim (China) Investment Co Ltd
Inactive CompaniesN/A
Active IndicationsProteinuriaRenal Insufficiency, ChronicNephrosis +[5] 
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A